COLITE ULCEROSA DELL’ADULTO: epidemiologia, fisiopatologia, diagnosi, e terapia. OTTIMA REVIEW DA”JAMA”.
Ulcerative Colitis in Adults A Review Beatriz Gros, MD; Gilaad G. Kaplan, MD, MPH This review focuses on the epidemiology,…
Ulcerative Colitis in Adults A Review Beatriz Gros, MD; Gilaad G. Kaplan, MD, MPH This review focuses on the epidemiology,…
Early Ileocecal Resection for Crohn’s Disease Is Associated With Improved Long-term Outcomes Compared With Anti-Tumor Necrosis Factor Therapy: A Population-Based…
Defining Interactions Between the Genome, Epigenome, and the Environment in Inflammatory Bowel Disease: Progress and Prospects Alexandra J. Noble et…
Biopsy and blood-based molecular biomarker of inflammation in IBD Carmen Argmann et al ABSTRACT Objective IBD therapies and treatments are evolving…
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease Loris Riccardo…
Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing June Tome et al. Abstract BACKGROUND Bile…
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis Siddharth Singh et al. Background…
Use of biologics for the management of Crohn’s disease: IG-IBD clinical guidelines based on the GRADE methodology FABIO MACALUSO ED…
GUT MICROBIAL METABOLISM OF 5-ASA IS PROSPECTIVELY ASSOCIATED WITH TREATMENT FAILURE IN PATIENTS WITH IBD Raaj Mehta et al. Abstract…
Dietary interventions for the treatment of inflammatory bowel diseases: an updated systematic review and meta-analysis Berkeley N. Limketkai et al.…
Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn- or postbiotics?…
Understanding the development and function of the gut microbiota in health and inflammation Deepak Selvakuma et al. Abstract The…
Self-expandable metal stents versus endoscopic balloon dilation for the treatment of strictures in Crohn’s disease (ProtDilat study): an open-label, multicentre,…
Systematic review with meta-analysis: the effectiveness of either ustekinumab or vedolizumab in patients with Crohn’s disease refractory to anti-tumour necrosis…
Systemic Inflammation in Preclinical Ulcerative Colitis Daniel Bergemalm et al. BACKGROUND & AIMS: Preclinical ulcerative colitis is poorly defined. We…
AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review Sanjay K.…
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease Daniel C. Baumgart et al. Crohn’s disease and ulcerative colitis, together…
The Microbiome as a Therapy in Pouchitis and Ulcerative Colitis Jean-Frédéric LeBlanc et al. Abstract The gut microbiome has been…
Healthy Cotwins Share Gut Microbiome Signatures With Their Inflammatory Bowel Disease Twins and Unrelated Patients Eelco C. Brand et al.…
The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable Anita Afzali et al. Abstract In the USA, an…
European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations Stephan Miehlke et al.…
The Global Incidence of Faecal Microbiota Transplantation-related Adverse Events From 2000 to 2020 Cicilia Marcella et al. Abstract Background: Faecal microbiota…
The influence of proton pump inhibitor therapy on the outcome of infliximab therapy in inflammatory bowel disease: a patient-level meta-analysis…
The intestinal barrier, an arbitrator turned provocateur in IBD Mehandru S, and Colombel JF Key studies published in 2020 demonstrate…